| 3701 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
12 |
| 3702 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2021 |
Standard Therapy |
Poland |
32 |
| 3703 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2021 |
Standard Therapy |
Poland |
1 |
| 3704 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2021 |
Standard Therapy |
Poland |
1 |
| 3705 |
Bone Marrow |
Allogeneic |
Wiskott-Aldrich Syndrome |
Hematology |
2021 |
Standard Therapy |
Poland |
9 months |
| 3706 |
Apheresis |
Allogeneic |
Acute Biphenotypic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
28 |
| 3707 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
17 |
| 3708 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
73 |
| 3709 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
38 |
| 3710 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
31 |
| 3711 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
24 |
| 3712 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
27 |
| 3713 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
54 |
| 3714 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
51 |
| 3715 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
65 |
| 3716 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
47 |
| 3717 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
10 |
| 3718 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
23 |
| 3719 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
5 |
| 3720 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
28 |
| 3721 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
58 |
| 3722 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
13 |
| 3723 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
55 |
| 3724 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
42 |
| 3725 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
20 |
| 3726 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
58 |
| 3727 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
52 |
| 3728 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
68 |
| 3729 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
32 |
| 3730 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
19 |
| 3731 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
61 |
| 3732 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
42 |
| 3733 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
3 |
| 3734 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
29 |
| 3735 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
8 |
| 3736 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
54 |
| 3737 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
20 |
| 3738 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
6 |
| 3739 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
61 |
| 3740 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
24 |
| 3741 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
66 |
| 3742 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
38 |
| 3743 |
Apheresis |
Allogeneic |
Acute Lymphoblastic Leukemia – Relapse |
Hematology |
2021 |
Standard Therapy |
Poland |
38 |
| 3744 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
40 |
| 3745 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
58 |
| 3746 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
23 |
| 3747 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
59 |
| 3748 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
62 |
| 3749 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
73 |
| 3750 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
41 |
| 3751 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
48 |
| 3752 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
64 |
| 3753 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
24 |
| 3754 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
50 |
| 3755 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
55 |
| 3756 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
66 |
| 3757 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
46 |
| 3758 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
69 |
| 3759 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
47 |
| 3760 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
45 |
| 3761 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
70 |
| 3762 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
68 |
| 3763 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
70 |
| 3764 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
63 |
| 3765 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
37 |
| 3766 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
21 |
| 3767 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
60 |
| 3768 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
20 |
| 3769 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
43 |
| 3770 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
56 |
| 3771 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
58 |
| 3772 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
60 |
| 3773 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
65 |
| 3774 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
53 |
| 3775 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
56 |
| 3776 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
64 |
| 3777 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
61 |
| 3778 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
63 |
| 3779 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
41 |
| 3780 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
59 |
| 3781 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
73 |
| 3782 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
41 |
| 3783 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
32 |
| 3784 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
58 |
| 3785 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
62 |
| 3786 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
69 |
| 3787 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
58 |
| 3788 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
38 |
| 3789 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
40 |
| 3790 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
69 |
| 3791 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
64 |
| 3792 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
66 |
| 3793 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
28 |
| 3794 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
48 |
| 3795 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
52 |
| 3796 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
40 |
| 3797 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
41 |
| 3798 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
58 |
| 3799 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
45 |
| 3800 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2021 |
Standard Therapy |
Poland |
60 |